Axys Shareholders to Meet in Mid-November to Discuss Celera Deal | GenomeWeb

NEW YORK, Oct. 16 – Celera Genomics and Axys Pharmaceuticals have planned “a special meeting” on Nov. 16 at 1:00 p.m. EST to discuss the proposed acquisition of Axys by Celera’s parent company Applera, the companies announced on Tuesday.

The meeting will be held at Axys' headquarters in South San Francisco, Calif. Proxy statement for the meeting are expected to be mailed on or about Oct. 16 to Axys stockholders of record as of Oct. 1, 2001.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.